公司概覽
業務類別 Diagnostics & Research
業務概覽 Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
公司地址 322 North 2200 West, Salt Lake City, UT, USA, 84116
電話號碼 +1 801 584-3600
傳真號碼 +1 801 584-3640
公司網頁 https://www.myriad.com
員工數量 2700
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Samraat S. Raha President, Chief Executive Officer and Director 美元 750.00K 24/02/2026
Mr. Mark S. Verratti Chief Operating Officer 美元 552.34K 24/02/2025
Ms. Shereen Solaiman Chief People Officer -- 09/04/2025
Ms. Margaret Ancona Senior Vice President and Chief of Staff -- 09/04/2025
Mr. Kevin Richard Haas Chief Technology Officer -- 09/04/2025
Mr. Dale Muzzey Chief Scientific Officer 美元 499.35K 09/04/2025
Mr. Benjamin R. Wheeler Chief Financial Officer and Principal Accounting Officer -- 24/02/2026
Ms. Jennifer Fox Chief Legal Officer -- 09/04/2025
 
董事會成員
董事會 職務 更新日期
Dr. Heiner Dreismann,PhD Independent Director 24/02/2026
Mr. Mark S. Davis Independent Director 24/02/2026
Ms. S. Louise Phanstiel Chairman of the Board 24/02/2026
Mr. Samraat S. Raha President, Chief Executive Officer and Director 24/02/2026
Dr. Daniel M. Skovronsky, M.D.,PhD Independent Director 24/02/2026
Ms. Colleen F. Reitan Independent Director 24/02/2026
Dr. Lee N. Newcomer, M.D. Independent Director 24/02/2026
Ms. Rashmi Kumar Independent Director 24/02/2026
Mr. Paul M. Bisaro Independent Director 24/02/2026
 
所屬ETF (更新日期: 07/03/2026 04:11)
代號 名稱 佔比% 持有日期
RFLRInnovator U.S. Small Cp Mgd Flr ETF0.004%25/02/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.004%28/02/2026
SPGMState Street® SPDR® Ptf MSCIGlbStkMktETF0.003%27/02/2026
AVUSAvantis US Equity ETF0.003%28/02/2026
AVTMAvantis Total Equity Markets ETF0.002%28/02/2026
FEACFidelity Enhanced U.S. All-Cap Eq ETF0.001%27/02/2026
VLUState Street® SPDR® S&P® 1500 ValTiltETF0.001%27/02/2026
SAAProShares Ultra SmallCap6000.001%27/02/2026
ESIXState Street® SPDR® S&P SmCap 600 ESGETF0.001%27/02/2026
PBSMInvesco PureBeta MSCI USA Small Cap ETF0.0005%31/05/2023
HDGProShares Hedge Replication0.0001%27/02/2026
MMTMState Street® SPDR® S&P® 1500MomtTiltETF0.00001%27/02/2026
AVSUAvantis Responsible US Equity ETF0.000003%28/02/2026
AIEQAmplify AI Powered Equity ETF<0.000001%27/02/2026
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%27/02/2026
BBSCJPMorgan BetaBuilders US Sml Cp Eq ETF<0.000001%23/06/2025
DFUSDimensional US Equity Market ETF<0.000001%18/02/2026
EBILongview Advantage ETF<0.000001%10/06/2025
EKGFirst Trust Nasdaq Lux Dgtl Hlth SoluETF<0.000001%21/09/2025
ESGVVanguard ESG US Stock ETF<0.000001%30/09/2025
  1    2    3   4    5  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.